Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions

被引:0
|
作者
Kayo Fujita
Masayuki Kaneko
Mamoru Narukawa
机构
[1] Kitasato University,Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences
来源
关键词
Sitagliptin; Vildagliptin; Weighted Mean Difference; Saxagliptin; Japanese Subject;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:219 / 232
页数:13
相关论文
共 50 条
  • [1] Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions
    Fujita, Kayo
    Kaneko, Masayuki
    Narukawa, Mamoru
    CLINICAL DRUG INVESTIGATION, 2017, 37 (03) : 219 - 232
  • [2] Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
    Kim, Y. G.
    Hahn, S.
    Oh, T. J.
    Kwak, S. H.
    Park, K. S.
    Cho, Y. M.
    DIABETOLOGIA, 2013, 56 (04) : 696 - 708
  • [3] Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis
    Y. G. Kim
    S. Hahn
    T. J. Oh
    S. H. Kwak
    K. S. Park
    Y. M. Cho
    Diabetologia, 2013, 56 : 696 - 708
  • [4] EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Perez, A.
    Franch, J.
    Fuster, E.
    Paz, S.
    Prades, M.
    Granell, M.
    VALUE IN HEALTH, 2014, 17 (07) : A335 - A336
  • [5] Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Zhang, Fang
    Xu, Shishi
    Tang, Lizhi
    Pan, Xiaohui
    Tong, Nanwei
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [6] Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis
    Men, P.
    He, N.
    Song, C.
    Zhai, S.
    DIABETES & METABOLISM, 2017, 43 (06) : 493 - 500
  • [7] Systematic review and meta-analysis of efficacy and safety of combinational therapy with metformin and dipeptidyl peptidase-4 inhibitors
    Alanazi, Abdulrahman S.
    SAUDI PHARMACEUTICAL JOURNAL, 2015, 23 (06) : 603 - 613
  • [8] Systematic review and meta-analysis: dipeptidyl peptidase-4 inhibitors and rheumatoid arthritis risk
    Wang, Miao
    Li, Muqin
    Xie, Ying
    ENDOCRINE JOURNAL, 2021, 68 (06) : 729 - 738
  • [9] Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis
    Barkas, F.
    Elisaf, M.
    Tsimihodimos, V.
    Milionis, H.
    DIABETES & METABOLISM, 2017, 43 (01) : 1 - 8
  • [10] DIPEPTIDYL PEPTIDASE-4 INHIBITORS AND PROTECTION AGAINST STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Barkas, F.
    Elisaf, M.
    Tsimihodimos, V.
    Milionis, H.
    ATHEROSCLEROSIS, 2016, 252 : E223 - E223